Overview
ISIN
GB00BHSRZC82SEDOL
BHSRZC8Investment proposition
Share price and charges
Price
280.00pNAV at fair
273.39pPremium (+) or discount (-) at fair
2.4%Ongoing charges*
0.85%Fund facts
Active share
99%*
Fund launch date
1998
AIC Investment Sector
Global Smaller Companies
Benchmark
S&P Global Small Cap Index
*Relative to S&P Global Small Cap. Source: Baillie Gifford & Co, S&P.
While the policy is global investment, the approach adopted is to construct a portfolio through the identification of individual companies which offer long-term growth potential.
Meet the managers
Meet the directors
Intermediary client contacts
If you’d like further information, please get in touch with the Intermediary Client Contact for your area.
Ratings
Regulatory news announcements
Regulatory news announcements which are released to the London Stock Exchange can be accessed via their service.
The Association of Investment Companies
Further information on investment trusts and the investment trust sector can be found on The Association of Investment Companies website.
Risk Warnings
Risk Introduction
The investment trusts managed by Baillie Gifford & Co Limited are listed UK companies. The value of their shares, and any income from them, can fall as well as rise and investors may not get back the amount invested. The specific risks associated with the Trust include:
Currency
The Trust invests in overseas securities. Changes in the rates of exchange may also cause the value of your investment (and any income it may pay) to go down or up.
Private Companies
Unlisted investments such as private companies, in which the Trust has a significant investment, can increase risk. These assets may be more difficult to sell, so changes in their prices may be greater. If a private company's value increases significantly it may become a large part of the portfolio. This increases investment risk because of the greater impact of a fall in its value.
Gearing
The Trust can borrow money to make further investments (sometimes known as "gearing" or "leverage"). The risk is that when this money is repaid by the Trust, the value of the investments may not be enough to cover the borrowing and interest costs, and the Trust will make a loss. If the Trust's investments fall in value, any invested borrowings will increase the amount of this loss.
Liquidity
Values for securities which are difficult to trade such as private companies may not be readily available and there can be no assurance that any value assigned to such securities will accurately reflect the price the Trust might receive upon their sale.
Derivatives
The Trust can make use of derivatives which may impact on its performance.
Smaller Immature Companies
Investment in smaller, immature companies is generally considered higher risk as changes in their share prices may be greater and the shares may be harder to sell. Smaller, immature companies may do less well in periods of unfavourable economic conditions.
Premium Risk
Share prices may either be below (at a discount) or above (at a premium) the net asset value (NAV). The Trust may issue new shares when the price is at a premium which may reduce the share price. Shares bought at a premium may have a greater risk of loss than those bought at a discount.
Buy-backs
The Trust can buy back its own shares. The risks from borrowing, referred to above, are increased when a trust buys back its own shares.
Income Secondary
The aim of the Trust is to achieve capital growth. You should not expect a significant, or steady, annual income from the Trust.
Regulation of Investment Trusts
The Trust is listed on the London Stock Exchange and is not authorised or regulated by the Financial Conduct Authority.
Index disclaimer
Important information
Your location indicates you are based in Jersey and you have confirmed that you are an intermediary. The information in the website is not intended for retail investors. Please select “Change” at the top of the page if this is not suitable for you.
This website is informative only and the information provided should not be considered as investment or other advice or a recommendation to buy, sell or hold a particular investment. Read our Legal and regulatory information for further details.
Fund performance
Periodic Performance
As at: 30 April 2026
1 Year | 3 Years | 5 Years | 10 Years | |
|---|---|---|---|---|
Share Price | 52.2% | 57.5% | -34.4% | 165.2% |
NAV | 44.8% | 31.1% | -31.4% | 156.7% |
Index* | 33.0% | 45.8% | 39.7% | 179.9% |
Discrete Performance
As at: 31 March 2026
31/03/2021 – 31/03/2022 | 31/03/2022 – 31/03/2023 | 31/03/2023 – 31/03/2024 | 31/03/2024 – 31/03/2025 | 31/03/2025 – 31/03/2026 | |
|---|---|---|---|---|---|
Share Price | -32.0% | -30.4% | -4.0% | 5.4% | 38.2% |
NAV | -25.1% | -24.3% | -10.0% | -1.2% | 35.3% |
Index* | 4.2% | -2.7% | 13.8% | -2.6% | 21.0% |
Performance
As at: 30 April 2026
Source: Morningstar, MSCI, S&P.
Performance figures appear in GBP. The value of your investment may go down as well as up, and you may not get back the amount you invested.
Comparative Index is limited to a 5 year period from the current date.
The graph has been rebased to 100.
Please bear in mind that past performance is not a guide to future returns.
Active share
As at: 30 April 2026
Relative to S&P Global Small Cap. Source: Baillie Gifford & Co, S&P.
Discount/premium history at fair
As at: 30 April 2026
Source: Morningstar. Premium/Discount of share price to NAV at fair.
If the graph shows negative figures this means that the share price is lower than the NAV at fair – this is known as trading at a Discount.
If the graph shows positive figures this means that the share price is higher than the NAV at fair - this is known as trading at a Premium.
Fund portfolio holdings
The list of top 10 holdings that this fund invests in.
As at: 30 April 2026
| # | Holding | % of total assets |
|---|---|---|
| 1 | Space Exploration Technologies | 18.9% |
| 2 | PsiQuantum | 5.1% |
| 3 | Alnylam Pharmaceuticals | 4.2% |
| 4 | Aehr Test Systems | 2.8% |
| 5 | ASPEED Technology | 2.6% |
| 6 | Twist Bioscience | 2.4% |
| 7 | Xometry, Inc. | 2.2% |
| 8 | Axon Enterprise | 2.1% |
| 9 | American Superconductor Corp | 2.0% |
| 10 | Echodyne | 1.9% |
Insights
Key articles, videos and podcasts relating to the fund:
Filters
Insights
SpaceX: pre IPO briefing note
An update on our SpaceX holding amid IPO speculation.
Navigating the Iran shock
Edinburgh Worldwide discusses defence exposure and long-term growth discipline.
Software’s sudden derating
Edinburgh Worldwide finds resilient software companies amid the market’s reaction to AI disruption.
EWIT must-read 2026 shareholder letter
Safeguard your future: why your vote matters for Edinburgh Worldwide Investment Trust (EWIT)’s unique proposition.
EWIT enlightenment: Alnylam
The US drugmaker pivoting from a rare disease specialist to a major therapeutic platform.
EWIT enlightenment: IREN
The US datacentre operator turning renewable power into AI profits as grid constraints bite.
Bringing it home
Meet the companies winning from deglobalisation.
EWIT enlightenment: MP Materials
The owner of the US’s only rare earth mine is set for success, after a $500m partnership with Apple.
EWIT enlightenment: Amplitude
How software company Amplitude is adapting to the AI age.
EWIT enlightenment: Astera Labs
How this portfolio holding is solving critical data bottlenecks in AI infrastructure.
Edinburgh Worldwide Investment Trust Q4 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
SpaceX: pre IPO briefing note
An update on our SpaceX holding amid IPO speculation.Navigating the Iran shock
Edinburgh Worldwide discusses defence exposure and long-term growth discipline.Software’s sudden derating
Edinburgh Worldwide finds resilient software companies amid the market’s reaction to AI disruption.EWIT must-read 2026 shareholder letter
Safeguard your future: why your vote matters for Edinburgh Worldwide Investment Trust (EWIT)’s unique proposition.EWIT enlightenment: Alnylam
The US drugmaker pivoting from a rare disease specialist to a major therapeutic platform.EWIT enlightenment: IREN
The US datacentre operator turning renewable power into AI profits as grid constraints bite.Bringing it home
Meet the companies winning from deglobalisation.EWIT enlightenment: MP Materials
The owner of the US’s only rare earth mine is set for success, after a $500m partnership with Apple.EWIT enlightenment: Amplitude
How software company Amplitude is adapting to the AI age.EWIT enlightenment: Astera Labs
How this portfolio holding is solving critical data bottlenecks in AI infrastructure.
AGM and voting
When you invest in an investment trust you become a shareholder and have a say on how the Company is run. You also have a right to attend the Company's annual general meeting (AGM).
How to vote
The following link will take you through to The Association of Investment Trusts' (AIC) website where there is information on how to vote your shares if you hold them via one of the major platforms.
How to attend the AGM
If you hold your shares through a platform, it is not always obvious how to attend an AGM. The following link will take you through to The Association of Investment Trusts’ (AIC) website where there is information on how your platform can help you attend this important shareholder meeting. If you do not see your provider listed, please contact your provider directly and ask them to assist.
Edinburgh Worldwide Investment Trust corporate calendar
Our corporate calendar provides details of the regulatory events that occur over the year. This includes dates for reports, results, dividend payments and the AGM.
| Event | Month (each year) |
| Final results announced | January |
| Interim results announced | June |
| Financial year end date | 31 October |
| Annual general meeting | April |
| Dividends payable | N/A |
AGM
Edinburgh Worldwide's Requisitioned General Meeting and AGM was held on Friday 14 February 2025. You can read a summary of the results of the voting on AGM resolutions here.
Voting
A breakdown of the votes cast by Baillie Gifford over the previous quarter on behalf of the investment trust is available in the Proxy voting disclosure.
Registrar
Computershare Investor Services PLC maintains the share register on behalf of the Company. Queries regarding shares registered in your own name can be directed to:
Computershare Investor Service PLC,
The Pavilions,
Bridgwater Road,
Bristol,
BS99 6ZZ
T: +44 (0)370 707 1643
Documents
You can access any literature about the Fund here.
To download any document you will need Adobe Reader. Please note that we can now provide you with Braille and audio transcriptions of our literature on request. It may take up to 10 days for the transcription to be completed dependent on the size of the document.